Literature DB >> 6180607

Elevation of quinone reductase activity by anticarcinogenic antioxidants.

P Talalay, A M Benson.   

Abstract

NAD(P)H:quinone reductase exhibits broad specificity in the reduction of endogenous and exogenous quinones and quinone imines, such as those derived from polycyclic aromatic carcinogens, phenolic steroids, vitamin K, and numerous therapeutic drugs. This enzyme is found in several cell compartments and is widely distributed among tissues. In contrast to several other flavoprotein dehydrogenases, quinone reductase catalyzes obligatorily two electron reductions. Extensive studies by Huggins and by others have shown that the quinone reductase in liver and some other tissues of rats is inducible by various polycyclic hydrocarbons and aromatic amines, as well as by certain azo dyes. Huggins perceived that the relative effectiveness of such compounds in inducing quinone reductase correlated with their abilities to protect against toxicity and carcinogenesis. Certain antioxidants are also known to protect against the tumorigenic and toxic effects of carcinogens. Studies on the mechanisms underlying the protective effects of BHA, BHT, ethoxyquin, and disulfiram have revealed that these compounds alter the activity profiles of several enzymes which metabolize carcinogenic and toxic compounds. We have observed that quinone reductase specific activity is increased markedly in mouse liver and several extrahepatic tissues in response to dietary BHA, ethoxyquin, and disulfiram, whereas BHT has been shown by others to enhance this enzymatic activity in rat liver. These findings confirm and extend the correlation between the ability to elevate quinone reductase activity and to confer protection against carcinogenesis and toxicity. The broad specificity of quinone reductase, its apparent inability to catalyze one electron reductions of quinones, its widespread distribution, and its inducibility by a variety of structurally dissimilar protective compounds, suggest that quinone reductase may play a significant local protective role in various regions of the cell.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6180607     DOI: 10.1016/0065-2571(82)90021-8

Source DB:  PubMed          Journal:  Adv Enzyme Regul        ISSN: 0065-2571


  14 in total

1.  Vitamin K antagonism of coumarin anticoagulation. A dehydrogenase pathway in rat liver is responsible for the antagonistic effect.

Authors:  R Wallin
Journal:  Biochem J       Date:  1986-06-15       Impact factor: 3.857

2.  Dietary glucoraphanin-rich broccoli sprout extracts protect against UV radiation-induced skin carcinogenesis in SKH-1 hairless mice.

Authors:  Albena T Dinkova-Kostova; Jed W Fahey; Andrea L Benedict; Stephanie N Jenkins; Lingxiang Ye; Scott L Wehage; Paul Talalay
Journal:  Photochem Photobiol Sci       Date:  2010-04       Impact factor: 3.982

Review 3.  Cellular stress responses, the hormesis paradigm, and vitagenes: novel targets for therapeutic intervention in neurodegenerative disorders.

Authors:  Vittorio Calabrese; Carolin Cornelius; Albena T Dinkova-Kostova; Edward J Calabrese; Mark P Mattson
Journal:  Antioxid Redox Signal       Date:  2010-08-28       Impact factor: 8.401

4.  Induction of NAD(P)H:quinone reductase in murine hepatoma cells by phenolic antioxidants, azo dyes, and other chemoprotectors: a model system for the study of anticarcinogens.

Authors:  M J De Long; H J Prochaska; P Talalay
Journal:  Proc Natl Acad Sci U S A       Date:  1986-02       Impact factor: 11.205

5.  The role of natural products in revealing NRF2 function.

Authors:  Donna D Zhang; Eli Chapman
Journal:  Nat Prod Rep       Date:  2020-05-13       Impact factor: 13.423

6.  Capsaicin alleviates the imbalance in xenobiotic metabolizing enzymes and tumor markers during experimental lung tumorigenesis.

Authors:  P Anandakumar; S Kamaraj; S Jagan; G Ramakrishnan; C Naveenkumar; S Asokkumar; T Devaki
Journal:  Mol Cell Biochem       Date:  2009-05-18       Impact factor: 3.396

7.  An ethoxyquin-inducible aldehyde reductase from rat liver that metabolizes aflatoxin B1 defines a subfamily of aldo-keto reductases.

Authors:  E M Ellis; D J Judah; G E Neal; J D Hayes
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-01       Impact factor: 11.205

8.  Prevention of chemically induced mammary tumorigenesis by daidzein in pre-pubertal rats: the role of peroxidative damage and antioxidative enzymes.

Authors:  Prachi Mishra; Anand Kar; Raosaheb K Kale
Journal:  Mol Cell Biochem       Date:  2009-02-13       Impact factor: 3.396

9.  Aspirin-like drugs can protect human T lymphocytes against benzoquinone cytotoxicity: evidence for a NAD(P)H:quinone reductase-dependent mechanism.

Authors:  E Flescher; C A Snyder
Journal:  Arch Toxicol       Date:  1995       Impact factor: 5.153

Review 10.  Cellular approaches to bioreductive drug mechanisms.

Authors:  A M Rauth; R S Marshall; B L Kuehl
Journal:  Cancer Metastasis Rev       Date:  1993-06       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.